Mad Money: Jim Cramer on Market Optimism, J&J, Axon, and Keurig Dr Pepper

Market Optimism and Bearish Sentiment

• 📈 The market experienced a strong day with the Dow gaining 617 points, the S&P jumping 85%, and the NASDAQ climbing 72%, all closing at record highs.
• 💡 Many market cynics are baffled by positive events, struggling to remain bearish due to historical trends and the difficulty of convincing pessimists to turn positive.
• ⚠️ Factors contributing to a fraught backdrop include $37 trillion in federal debt, political uncertainty, and global geopolitical tensions.
• 🧠 Despite a slightly higher-than-expected CPI, a bullish prism focuses on jobless claims, reinforcing the possibility of Federal Reserve interest rate cuts.

Johnson & Johnson's Resilience

• 🚀 Johnson & Johnson (J&J) has been a standout healthcare stock, up 21.5% for the year, defying the sector's weakness.
• 🏥 J&J's strength comes from its robust medical device business (36% of sales) in areas like cardiovascular, orthopedic, surgery, and vision, bolstered by acquisitions.
• 💊 The pharmaceutical division, despite patent cliff issues with Stelara, is performing strongly, particularly in immunology with Tremfya and oncology, with ambitious growth targets.
• ⚖️ Wall Street is looking past J&J's talc lawsuits, as the company has shifted its legal strategy to fight claims individually, with some success.

Axon's Growth and Innovation

• ⚡ Axon Enterprise, formerly Taser International, has rallied nearly 800% in 5 years, driven by its law enforcement technology solutions.
• 📹 The company's future lies in body cameras and evidence management software, complemented by non-lethal weapons (Tasers) and emerging areas like surveillance drones and VR training.
• 📊 Axon's software and services division is a key profit driver, boasting high gross margins and strong annual recurring revenue growth, with excellent customer retention rates.
• 🤖 AI-enhanced productivity tools, such as generative AI assistants for report writing and redaction, are significantly reducing administrative burdens for law enforcement officers.

Keurig Dr Pepper's Strategic Shift

• 🥤 Keurig Dr Pepper announced plans to acquire JDE Peet's for $18.4 billion and then break up into separate coffee and soft drink businesses.
• 📉 The stock has plunged over 21% since the announcement, partly due to concerns about increased debt from the acquisition and the complexity of the breakup.
• 💡 Despite criticisms, the breakup is seen as a positive move, allowing each business to focus on its strengths and potentially unlocking shareholder value.
• 💰 The current valuation, with an enterprise multiple of 8.5% (or 11.4% with new debt), is considered a significant discount compared to peers like Coca-Cola and PepsiCo, making it a potential buying opportunity.

Lightning Round Highlights

• 💡 MP Materials is a company to watch, but investors should avoid buying more on margin.
• ⚕️ Questive Therapeutics and Lens Therapeutic are interesting companies in the pharmaceutical space that require further research.
• 🚆 Canadian National Railway is considered undervalued with a good yield and low P/E multiple.

Reflection on 9/11

• 🎗️ Jim Cramer reflects on the 24th anniversary of 9/11, urging remembrance and understanding of the tragic events.
• 💔 He shares personal memories of the day, the impact on Wall Street, and his involvement with Cantor Fitzgerald's annual charity day, supporting the baby's heart fund.